Allakos Investigational Site 218-001

Cincinnati, Ohio 45236

0 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitis — Stopped early